tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BBIO Stock Latest News

BridgeBio management to meet with Piper Sandler
The FlyBridgeBio management to meet with Piper Sandler
7d ago
BBIO
Positive Outlook on BridgeBio Pharma Driven by Promising Pipeline and Strategic Initiatives
PremiumRatings
Positive Outlook on BridgeBio Pharma Driven by Promising Pipeline and Strategic Initiatives
7d ago
BBIO
BridgeBio presented data from ATTRibute-CM study on acoramidis
PremiumThe Fly
BridgeBio presented data from ATTRibute-CM study on acoramidis
9d ago
BBIO
BridgeBio participates in a conference call with Piper Sandler
PremiumThe Fly
BridgeBio participates in a conference call with Piper Sandler
15d ago
BBIO
Positive Buy Rating for BridgeBio Pharma’s Encaleret Driven by Promising Phase 2 Results and Significant Market Potential
PremiumRatings
Positive Buy Rating for BridgeBio Pharma’s Encaleret Driven by Promising Phase 2 Results and Significant Market Potential
23d ago
BBIO
BridgeBio price target raised to $82 from $72 at UBS
PremiumThe FlyBridgeBio price target raised to $82 from $72 at UBS
26d ago
BBIO
Optimistic Buy Rating for BridgeBio Pharma: Promising ADH1 Treatment and Market Potential
Premium
Ratings
Optimistic Buy Rating for BridgeBio Pharma: Promising ADH1 Treatment and Market Potential
27d ago
BBIO
BridgeBio Pharma: Poised for Growth with Promising Pipeline and Upcoming Catalysts
Premium
Ratings
BridgeBio Pharma: Poised for Growth with Promising Pipeline and Upcoming Catalysts
30d ago
BBIO
BridgeBio Pharma’s Encaleret: Promising Developments and Potential Market Impact
PremiumRatings
BridgeBio Pharma’s Encaleret: Promising Developments and Potential Market Impact
30d ago
BBIO
BridgeBio announces results from Phase 2 study of encaleret
PremiumThe Fly
BridgeBio announces results from Phase 2 study of encaleret
1M ago
BBIO
3 Best Stocks to Buy Now, 9/3/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/3/2025, According to Top Analysts
1M ago
BBIO
VNOM
BridgeBio Pharma: Promising Pipeline and Market Position Drive Buy Rating
PremiumRatings
BridgeBio Pharma: Promising Pipeline and Market Position Drive Buy Rating
1M ago
BBIO
JPMorgan ups BridgeBio target, adds ‘Positive Catalyst Watch’
PremiumThe FlyJPMorgan ups BridgeBio target, adds ‘Positive Catalyst Watch’
1M ago
BBIO
3 Best Stocks to Buy Now, 9/2/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/2/2025, According to Top Analysts
1M ago
BBIO
MLYS
BridgeBio Pharma: Promising Phase 3 Data and Strong Financial Performance Justify Buy Rating
Premium
Ratings
BridgeBio Pharma: Promising Phase 3 Data and Strong Financial Performance Justify Buy Rating
1M ago
BBIO
BridgeBio presents data from ATTRibute-CM open label extension through month 42
PremiumThe Fly
BridgeBio presents data from ATTRibute-CM open label extension through month 42
1M ago
BBIO
BridgeBio price target raised to $70 from $56 at H.C. Wainwright
PremiumThe Fly
BridgeBio price target raised to $70 from $56 at H.C. Wainwright
1M ago
BBIO
BridgeBio Pharma’s Earnings Call Highlights Strong Growth
PremiumCompany Announcements
BridgeBio Pharma’s Earnings Call Highlights Strong Growth
2M ago
BBIO
BridgeBio price target raised to $57 from $55 at Scotiabank
PremiumThe Fly
BridgeBio price target raised to $57 from $55 at Scotiabank
2M ago
BBIO
BridgeBio price target raised to $61 from $60 at Oppenheimer
PremiumThe FlyBridgeBio price target raised to $61 from $60 at Oppenheimer
2M ago
BBIO
BridgeBio Pharma Reports Strong Q2 2025 Results
Premium
Company Announcements
BridgeBio Pharma Reports Strong Q2 2025 Results
2M ago
BBIO
Closing Bell Movers: Snap down 17%, Super Micro down 16% on earnings
Premium
The Fly
Closing Bell Movers: Snap down 17%, Super Micro down 16% on earnings
2M ago
AMD
LRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >